Filed under: Investing
Teva to Present at the Morgan Stanley Global Healthcare Conference
JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYS: TEVA) will host a live audio webcast at the Morgan Stanley Global Healthcare Conference in New York, New York. Jon Congleton, SVP & General Manager Global CNS will present on Monday, September 9, 2013 at 11:45 AM ET.
|
What: |
Teva Presentation at the Morgan Stanley Global Healthcare Conference | |||
|
Who: |
Jon Congleton, SVP & General Manager Global CNS, Teva Pharmaceutical Industries Ltd. | |||
|
When: |
Monday, September 9, 2013 | |||
|
Where: |
||||
|
How: |
Live over the Internet - log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva's website. |
|||
About Teva
Teva Pharmaceutical Industries Ltd. (NYS: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $20.3 billion in net revenues in 2012.
Teva Pharmaceutical Industries Ltd.
IR Contacts:
Kevin C. Mannix, 215-591-8912
United States
or
Tomer Amitai, 972 (3) 926-7656
Israel
or
PR Contacts:
Iris Beck Codner, 972 (3) 926-7246
Israel
or
Denise Bradley, 215-591-8974
United States
KEYWORDS: United States North America New York Middle East Israel
INDUSTRY KEYWORDS:
The article Teva to Present at the Morgan Stanley Global Healthcare Conference originally appeared on Fool.com.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
Read | Permalink | Email this | Linking Blogs | Comments